1. Is first- and second-line immunotherapy sequence the optimal strategy for unresectable hepatocellular carcinoma?. (March 2021) Authors: Celsa, C.; Cabibbo, G.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Stornello, C.; Giuffrida, P.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term outcomes of patients with chronic HBe-negative infection: Differences and transition between inactive carriers and low viremic carriers. (March 2023) Authors: Rizzo, G.E.M.; Bronte, F.; Rancatore, G.; Graceffa, P.; Falco, G.; Di Marco, V. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?. (March 2023) Authors: Celsa, C.; Cabibbo, G.; Rizzo, G.E.M.; Giuffrida, P.; Enea, M.; Di Maria, G.; Antonucci, M.; Giacchetto, C.M.; Rancatore, G.; Grassini, M.V.; Ciccia, R.; Grova, A.; Salvato, M.; Battaglia, S.; Vaccaro, M.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.04.3 FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS. (September 2021) Authors: Cabibbo, G.; Celsa, C.; Battaglia, S.; Enea, M.; Rizzo, G.E.M.; Busacca, A.; Petta, S.; Calvaruso, V.; Di Marco, V.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.08.2 NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: WHO IS THE WINNER?. (March 2023) Authors: Celsa, C.; Cabibbo, G.; Rizzo, G.E.M.; Giuffrida, P.; Di Maria, G.; Battaglia, S.; Vaccaro, M.; Enea, M.; Giacchetto, C.; Rancatore, G.; Grassini, M.; Ciccia, R.; Grova, A.; Salvato, M.; Camma, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.08.4 RISK FACTORS FOR VIRAL REACTIVATION IN PATIENTS WITH OVERT OR OCCULT HEPATITIS B VIRUS INFECTION RECEIVING IMMUNOSUPPRESSIVE TREATMENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. (March 2023) Authors: Rizzo, G.E.M.; Celsa, C.; Enea, M.; Rancatore, G.; Graceffa, P.; Falco, G.; Rizzo, C.; Destro Castaniti, G.; Madonia, G.; Di Stefano, V.; Tilotta, G.; Agliastro, G.; Vaccaro, M.; Di Maria, G.; Calvaruso, V.; Camma, C.; Di Marco, V. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.12.2 RESIST CRITERIA: A BIOCHEMICAL ALGORITHM TO REDUCE THE NUMBER OF UNNECESSARY UPPER ENDOSCOPIES FOR THE EVALUATION OF PORTAL HYPERTENSION IN COMPENSATED HBVCIRRHOTIC PATIENTS. (March 2023) Authors: Calvaruso, V.; Celsa, C.; Degasperi, E.; Di Maria, G.; Fichera, A.; Graceffa, P.; Rancatore, G.; Falco, G.; Di Martino, V.; Rizzo, G.E.M.; Grasso, M.; Simone, F.; Anolli, M.; Lampertico, P.; Craxi, A.; Di Marco, V.; Camma, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 2 Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma. (March 2021) Authors: Celsa, C.; Cabibbo, G.; Enea, M.; Battaglia, S.; Rizzo, G.E.M.; Busacca, A.; Matranga, D.; Attanasio, M.; Reig, M.; Craxì, A.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. RESIST Criteria: A biochemical algorithm to reduce the number of unnecessary upper endoscopies for the evaluation of portal hypertension in compensated HBV-cirrhotic patients. (March 2023) Authors: Calvaruso, V.; Celsa, C.; Degasperi, E.; Di Maria, G.; Fichera, A.; Graceffa, P.; Rancatore, G.; Falco, G.; Di Martino, V.; Rizzo, G.E.M.; Grasso, M.; Bronte, F.; Simone, F.; Anolli, M.P.; Lampertico, P.; Craxì, A.; Di Marco, V.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk factors for viral reactivation in patients with overt or occult Hepatitis B Virus infection receiving immunosuppressive treatments: A systematic review and meta-analysis with decision curve analysis. (March 2023) Authors: Rizzo, G.E.M.; Celsa, C.; Enea, M.; Di Maria, G.; Vaccaro, M.; Rancatore, G.; Graceffa, P.; Falco, G.; Calvaruso, V.; Di Marco, V.; Cammà, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗